Literature DB >> 11122954

Prevalence and risk factors of sexual dysfunction in men and women.

R C Rosen1.   

Abstract

Sexual dysfunctions are highly prevalent, affecting about 43% of women and 31% of men. Hypoactive sexual desire disorder has been reported in approximately 30% of women and 15% of men in population-based studies, and is associated with a wide variety of medical and psychologic causes. Sexual arousal disorders, including erectile dysfunction in men and female sexual arousal disorder in women, are found in 10% to 20% of men and women, and is strongly age-related in men. Orgasmic disorder is relatively common in women, affecting about 10% to 15% in community-based studies. In contrast, premature ejaculation is the most common sexual complaint of men, with a reporting rate of approximately 30% in most studies. Finally, sexual pain disorders have been reported in 10% to 15% of women and less than 5% of men. In addition to their widespread prevalence, sexual dysfunctions have been found to impact significantly on interpersonal functioning and overall quality of life in both men and women.

Entities:  

Mesh:

Year:  2000        PMID: 11122954     DOI: 10.1007/s11920-996-0006-2

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  25 in total

Review 1.  The sexual pain disorders: is the pain sexual or is the sex painful?

Authors:  Y M Binik; M Meana; K Berkley; S Khalifé
Journal:  Annu Rev Sex Res       Date:  1999

2.  On life satisfaction in male erectile dysfunction.

Authors:  A R Fugl-Meyer; G Lodnert; I B Bränholm; K S Fugl-Meyer
Journal:  Int J Impot Res       Date:  1997-09       Impact factor: 2.896

3.  Does the CAT technique enhance female orgasm?

Authors:  H S Kaplan
Journal:  J Sex Marital Ther       Date:  1992

4.  Attitudinal and experiential correlates of anorgasmia.

Authors:  M P Kelly; D S Strassberg; J R Kircher
Journal:  Arch Sex Behav       Date:  1990-04

Review 5.  Incidence and prevalence of the sexual dysfunctions: a critical review of the empirical literature.

Authors:  I P Spector; M P Carey
Journal:  Arch Sex Behav       Date:  1990-08

Review 6.  Painful coitus: a review of female dyspareunia.

Authors:  M Meana; Y M Binik
Journal:  J Nerv Ment Dis       Date:  1994-05       Impact factor: 2.254

7.  Sexual dysfunction in the United States: prevalence and predictors.

Authors:  E O Laumann; A Paik; R C Rosen
Journal:  JAMA       Date:  1999-02-10       Impact factor: 56.272

Review 8.  An evaluation of therapeutic programs for the treatment of secondary inorgasmia in women.

Authors:  M P McCabe; S M Delaney
Journal:  Arch Sex Behav       Date:  1992-02

Review 9.  Dyspareunia. A special type of chronic pelvic pain.

Authors:  J F Steege; F W Ling
Journal:  Obstet Gynecol Clin North Am       Date:  1993-12       Impact factor: 2.844

10.  Prevalence of sexual dysfunction in women: results of a survey study of 329 women in an outpatient gynecological clinic.

Authors:  R C Rosen; J F Taylor; S R Leiblum; G A Bachmann
Journal:  J Sex Marital Ther       Date:  1993
View more
  41 in total

1.  Sexual dysfunction in female hypertensives.

Authors:  Basil N Okeahialam; Ndudim C Obeka
Journal:  J Natl Med Assoc       Date:  2006-04       Impact factor: 1.798

2.  Current concepts in ejaculatory dysfunction.

Authors:  Jeffrey P Wolters; Wayne J G Hellstrom
Journal:  Rev Urol       Date:  2006

3.  Sexual function changes during pregnancy.

Authors:  Cara Ninivaggio; Rebecca G Rogers; Lawrence Leeman; Laura Migliaccio; Dusty Teaf; Clifford Qualls
Journal:  Int Urogynecol J       Date:  2016-11-26       Impact factor: 2.894

4.  Sexual morbidity associated with poorer psychological adjustment among gynecological cancer survivors.

Authors:  Anna O Levin; Kristen M Carpenter; Jeffrey M Fowler; Brittany M Brothers; Barbara L Andersen; G Larry Maxwell
Journal:  Int J Gynecol Cancer       Date:  2010-04       Impact factor: 3.437

5.  Sexual dysfunction in women with obstructive sleep apnea.

Authors:  Shyam Subramanian; Swetha Bopparaju; Ashesh Desai; Tammy Wiggins; Cheryl Rambaud; Salim Surani
Journal:  Sleep Breath       Date:  2009-08-11       Impact factor: 2.816

Review 6.  Evaluation and treatment of female sexual disorders.

Authors:  Sheryl Kingsberg; Stanley E Althof
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-05

Review 7.  Erectile dysfunction and cardiovascular disease: efficacy and safety of phosphodiesterase type 5 inhibitors in men with both conditions.

Authors:  Ajay Nehra
Journal:  Mayo Clin Proc       Date:  2009-02       Impact factor: 7.616

Review 8.  Clinical factors associated with sexual dysfunction among men in methadone maintenance treatment and buprenorphine maintenance treatment: a meta-analysis study.

Authors:  A Yee; H S Loh; H M B Hisham Hashim; C G Ng
Journal:  Int J Impot Res       Date:  2014-07-03       Impact factor: 2.896

9.  Selective facilitation of sexual solicitation in the female rat by a melanocortin receptor agonist.

Authors:  James G Pfaus; Annette Shadiack; Tanya Van Soest; Maric Tse; Perry Molinoff
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-28       Impact factor: 11.205

10.  Improvement in duration of erection following phosphodiesterase type 5 inhibitor therapy with vardenafil in men with erectile dysfunction: the ENDURANCE study.

Authors:  M T Rosenberg; P L Adams; T A McBride; J N Roberts; S W McCallum
Journal:  Int J Clin Pract       Date:  2009-01       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.